CTOs on the Move

Morse Laboratories

www.morselabs.com

 
Morse Laboratories is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Universal Health Services

Universal Health Services, Inc. (NYSE: UHS) is a Fortune 500 company based in King of Prussia, Pennsylvania. UHS owns and operates acute care hospitals, behavioral health centers, and ambulatory surgery centers in 37 states, Puerto Rico and the U.S. Virgin Islands. Universal Health Services, Inc. (UHS) is one of the largest hospital management companies in the United States. Through its subsidiaries, UHS operates 226 acute care hospitals, behavioral health facilities and ambulatory surgery centers. The company employs more than 60,000 people.

Dedicated Phase 1

Dedicated Phase 1 is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sturdy Memorial Hospital

Sturdy Memorial Hospital Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Sturdy Memorial Hospital Inc. is based in Attleboro, MA. You can find more information on Sturdy Memorial Hospital Inc. at www.sturdymemorial.org

MEDWRITE Medical Communications

MEDWRITE Medical Communications is a Maiden Rock, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.